Participants respond favorably to ePST®.
Two published clinical studies and a recent randomized clinical trial demonstrate that ePST® can effectively treat depression, is easy to use, well-accepted, and facilitates a therapeutic bond that is nearly equivalent to that experienced in live therapy.
First, in a small randomized trial at Beth Israel Deaconess Medical Center (BIDMC), participants found ePST to be highly usable, acceptable, and credible as a means of receiving Problem-Solving Treatment. All participants randomized to ePST completed all 6 treatment sessions and showed improvement in depressive symptoms (Figure 1).
In a subsequent trial at Dartmouth-Hitchcock Medical Center (DHMC) 23 completers of ePST showed reductions in depression comparable to results of PST delivered by live therapists (Figure 2). Diagnosis of major depressive disorder dropped from 80% to 11% of the sample after using ePST (Figure 3). The completion rate was 80%.
In a third study, also at BIDMC, participants randomized to ePST showed significantly greater improvement in depression than those in the waitlist group (Figure 4). Of the 25 participants randomized to ePST, 100% completed treatment.
These trials, together with the extensive research on live PST as a therapy for depression, indicate that ePST can effectively treat depression, and that users readily accept and respond favorably to this form of treatment delivery.
We welcome additional research partners, please contact us for more information.